FDA is criticised for poor oversight of drug companies' promotion of off-label drug use

被引：0
|
作者：
Tanne, Janice Hopkins
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2008年 / 337卷 / 7665期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Off-Label Drug Use and Promotion
    Gianutsos, Gerald
    US PHARMACIST, 2014, 39 (10) : 55 - 64
  • [2] FDA off-track on off-label drug promotion
    不详
    LANCET, 2007, 370 (9604): : 1976 - 1976
  • [3] Off-Label Drug Promotion and the Use of Disclaimers
    McKenney, Dina
    TEXAS LAW REVIEW, 2013, 92 (01) : 231 - 252
  • [4] FDA Regulation of Off-label Drug Promotion Under Attack
    Kesselheim, Aaron S.
    Mello, Michelle M.
    Avorn, Jerry
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05): : 445 - 446
  • [5] Off-label drug promotion
    不详
    ONCOLOGY-NEW YORK, 1999, 13 (12): : 1616 - 1616
  • [6] Manufacturers' promotion of off-label drug use: implications for drug safety
    Zieve, Allison
    Carome, Michael A.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (09) : 1149 - 1151
  • [7] FDA may allow drug companies to promote "off-label" uses
    Tanne, Janice Hopkins
    BRITISH MEDICAL JOURNAL, 2007, 335 (7632): : 1229 - 1229
  • [8] Regulating off-label drug use - Rethinking the role of the FDA
    Stafford, Randall S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14): : 1427 - 1429
  • [9] Off-label drug use in children
    Jain S.S.
    Bavdekar S.B.
    Gogtay N.J.
    Sadawarte P.A.
    The Indian Journal of Pediatrics, 2008, 75 (11) : 1133 - 1136
  • [10] Appropriate off-label drug use
    Lee, Sang Moo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2018, 61 (03): : 140 - 146
12345